[1]BELCHER JM, GARCIA-TSAO G, SANYAL AJ, et al.Association of AKI with mortality and complications in hospitalized patients with cirrhosis[J].Hepatology, 2013, 57 (2) :753-762.
|
[2]WONG F, O'LEARY JG, REDDY KR, et al.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection[J].Gastroenterology, 2013, 145 (6) :1280-1288.
|
[3]BELCHER JM.Acute kidney injury in liver disease:Role of biomarkers[J].Adv Chronic Kidney Dis, 2015, 22 (5) :368-375.
|
[4]ARROYO V, FERNANDEZ J.Management of hepatorenal syndrome in patients with cirrhosis[J].Nat Rev Nephrol, 2011, 7 (9) :517-526.
|
[5]BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J].Hepatology, 2014, 60 (2) :622-632.
|
[6]GUO DH, XU YQ.Clinical significance of urinary angiotensinogen[J].Chin J Integ Trad Western Nephrol, 2016, 17 (2) :187-188. (in Chinese) 郭冬华, 徐延琴.尿血管紧张素原的临床意义[J].中国中西医结合肾病杂志, 2016, 17 (2) :187-188.
|
[7]ZHANG XY, LYU WL, TENG J, et al.Correlation between urinary angiotensinogen and intrarenal renin-angiotensin system activity in chronic kidney disease patients[J].Chin J Nephrol, 2011, 27 (5) :327-332. (in Chinese) 章晓燕, 吕文律, 滕杰, 等.慢性肾脏病患者尿血管紧张素原与肾脏肾素血管紧张素系统活性的相关性[J].中华肾脏病杂志, 2011, 27 (5) :327-332.
|
[8]KOBORI H, OZAWA Y, SUZAKI Y, et al.Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats[J].J Am Soc Nephrol, 2005, 16 (7) :2073-2080.
|
[9]JURETZKO A, STEINBACH A, HANNEMANN A, et al.Urinary angiotensinogen and renin excretion are associated with chronic kidney disease[J].Kidney Blood Press Res, 2017, 42 (1) :145-155.
|
[10]BA AS, SANCHEZ A, BATLLE D.Angiotensinogen as a biomarker of acute kidney injury[J].Clin Kidney J, 2017, 10 (6) :759-768.
|
[11]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention andtreatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[12]ANGELI P, GINES P, WONG F, et al.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Ascites[J].J Hepatol, 2015, 62 (4) :968-974.
|
[13]WAGENER G, JAN M, KIM M, et al.Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery[J].Anesthesiology, 2006, 105 (3) :485-491.
|
[14]ALGE JL, KARAKALA N, NEELY BA, et al.Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit[J].Crit Care, 2013, 17 (2) :r69.
|
[15]YANG X, CHEN C, TIAN J, et al.Urinary angiotensinogen level predicts AKI in acute decompensated heart failure:A prospective, two-stage study[J].J Am Soc Nephrol, 2015, 26 (8) :2032-2041.
|
[16]LI YM, ZHOU FF, LUO Q.Research progress of non-vasomotor mechanism for cirrhosis complicated by kidney injury[J].Chin JGen Prac, 2017, 15 (8) :1407-1410. (in Chinese) 李宇玫, 周芳芳, 罗群.肝硬化并发急性肾损伤的非血管舒张机制的研究进展[J].中华全科医学, 2017, 15 (8) :1407-1410.
|
[17]TSIGOU E, PSALLIDA V, DEMPONERAS C, et al.Role of new biomarkers:Functional and structural damage[J].Crit Care Res Pract, 2013, 2013:361078.
|
[18]KASHANI K, CHEUNGPASITPORN W, RONCO C.Biomarkers of acute kidney injury:The pathway from discovery to clinical adoption[J].Clin Chem Lab Med, 2017, 55 (8) :1074-1089.
|
[19]BARRETO R, FAGUNDES C, MOREIRA R, et al.Urinary kidney injury molecule-1 (Kim-1) in the assessment of acute kidney injury in patients with cirrhosis[J].J Hepatol, 2013, 58 (3) :419.
|
[20]ROGNANT N, LEMOINE S.Evaluation of renal function in patients with cirrhosis:Where are we now?[J].World J Gastroenterol, 2014, 20 (10) :2533-2541.
|
[21] BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J].Hepatology, 2014, 60 (2) :622-632.
|
[22]GUNGOR G, ATASEVEN H, DEMIR A, et al.Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome:a prospective observational study[J].Liver Int, 2014, 34 (1) :49-57.
|
[23]FAGUNDES C, PEPIN MN, GUEVARA M, et al.Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis[J].J Hepatol, 2012, 57 (2) :267-273.
|
[24]XU CH, JIANG KR.Value of serum and urinary neutrophil gelatinase-associated lipocalin and cystatin C in diagnosis of liver cirrhosis complicated by acute kidney injury[H].J Clin Hepatol, 2017, 33 (11) :2136-2140. (in Chinese) 许长红, 江坤仁.血、尿中性粒细胞明胶酶相关脂质运载蛋白与胱抑素C对肝硬化并发急性肾损伤的诊断价值[J].临床肝胆病杂志, 2017, 33 (11) :2136-2140.
|
1. | 周阳丹,曹运强. 肝硬化合并自发性细菌性腹膜炎血浆PCT、PGE2、D-D、NGAL水平变化. 临床消化病杂志. 2023(01): 34-37 . ![]() | |
2. | 刘清清,杨婧,胡绍山,李苹菊,金秋,马红琳. 肝硬化肾损伤的发病机制与诊治进展. 临床肝胆病杂志. 2023(06): 1461-1467 . ![]() | |
3. | 周彪. 血清和尿液中CXCL16对过敏性紫癜患儿早期肾损伤的相关性. 辽宁医学杂志. 2021(01): 1-3 . ![]() | |
4. | 王钰琛,王勤英. 尿N-乙酰-β-D-氨基葡萄糖苷酶 尿视黄醇结合蛋白 尿β_2微球蛋白联合检测对乙肝肝硬化患者早期肾损伤诊断的临床价值. 中国药物与临床. 2021(22): 3671-3674 . ![]() | |
5. | 韩学贞,位晨晨. 胱抑素C、NGAL检测在肝硬化并发急性肾损伤早期诊断中的应用价值. 河南医学研究. 2020(06): 992-995 . ![]() | |
6. | 宁琪琪,高原,段美丽,刘海霞,孟庆华,于红卫,胡中杰,朱跃科. 局部枸橼酸抗凝在接受连续性肾脏替代治疗的肝病合并急性肾损伤中的应用效果观察. 临床肝胆病杂志. 2020(05): 1055-1058 . ![]() | |
7. | 薛顺和,张锦,陈兰兰,韩文. 胱抑素C和β2微球蛋白联合检测在肝硬化合并不同类型肾损伤中的诊断效能. 中国肝脏病杂志(电子版). 2020(03): 65-71 . ![]() |